Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.79
(-1.56%)
CNY 3.79
(-1.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 19.41 Billion | 21.61 Billion | 18.03 Billion | 11.51 Billion | 5.78 Billion | 5.76 Billion |
| Cost of Revenue | 20.76 Billion | 20.66 Billion | 17.78 Billion | 9.52 Billion | 5.05 Billion | 4.97 Billion |
| Gross Profit | -1.34 Billion | 948.24 Million | 257.65 Million | 1.98 Billion | 737.56 Million | 789.15 Million |
| Operating Expenses | 2.34 Billion | 1.2 Billion | 1.05 Billion | 730.61 Million | 518.08 Million | 665.11 Million |
| Selling, General and Administrative Expenses | 953.98 Million | 580.77 Million | 504.66 Million | 389.93 Million | 314.44 Million | 455.14 Million |
| Research and Development Expenses | 148.85 Million | 161.67 Million | 113.87 Million | 65.36 Million | 72.85 Million | 109.73 Million |
| Other Expenses | 1.07 Billion | 462.41 Million | 437.9 Million | 275.32 Million | 130.79 Million | -1.7 Million |
| Cost and Expenses | 23.1 Billion | 21.86 Billion | 18.83 Billion | 10.25 Billion | 5.56 Billion | 5.63 Billion |
| Operating Income | -2.66 Billion | -386.66 Million | -886.83 Million | 965.62 Million | 208.74 Million | 21.58 Million |
| Interest Expense | 574.05 Million | 505.83 Million | 418.76 Million | 177.15 Million | 90.75 Million | 68.52 Million |
| Income Tax Expense | 87.05 Million | -68.08 Million | 29.34 Million | -23.08 Million | -22.61 Million | 9.63 Million |
| Earnings before Tax | -3.66 Billion | -1.29 Billion | -1.82 Billion | 970.51 Million | 77.74 Million | 19.88 Million |
| Net Income | -3.65 Billion | -1.22 Billion | -1.85 Billion | 993.6 Million | 100.35 Million | 30.12 Million |
| Earnings Per Share Basic | -4.21 | -1.58 | -3.36 | 1.65 | 0.18 | 0.06 |
| Earnings Per Share Diluted | -4.21 | -1.58 | -3.36 | 1.58 | 0.18 | 0.05 |
| Weighted Average Shares Outstanding | 867.17 Million | 775.39 Million | 550.55 Million | 603.14 Million | 545.99 Million | 545.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 867.17 Million | 775.39 Million | 550.55 Million | 629.65 Million | 545.99 Million | 559.47 Million |
| Gross Margin | -0.07 | 0.04 | 0.01 | 0.17 | 0.13 | 0.14 |
| EBIT Margin | -0.07 | 0.04 | 0.01 | 0.14 | 0.06 | 0.04 |
| Profit Margin | -0.19 | -0.06 | -0.10 | 0.09 | 0.02 | 0.01 |
| EBITDA | -1.34 Billion | 500.42 Million | -269.95 Million | 1.47 Billion | 323.93 Million | 193.46 Million |
| Earnings Before Tax Margin | -0.14 | -0.02 | -0.05 | 0.08 | 0.04 | 0.00 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.26 Billion | 2.24 Billion | 2.4 Billion | 4.27 Billion | 19.41 Billion | 5.11 Billion |
| Cost of Revenue | 2.09 Billion | 2.1 Billion | 2.45 Billion | 4.92 Billion | 20.57 Billion | 5.28 Billion |
| Gross Profit | 172.39 Million | 138.69 Million | -50.24 Million | -659.14 Million | -1.15 Billion | -175.42 Million |
| Operating Expenses | 303.33 Million | 282.99 Million | 299.73 Million | 1.08 Billion | 1.5 Billion | 258.42 Million |
| Selling, General and Administrative Expenses | 292.93 Million | -75.16 Million | 285.17 Million | 279.58 Million | - | 500.25 Million |
| Research and Development Expenses | 10.4 Million | 14.84 Million | 14.55 Million | 34.1 Million | - | 31.44 Million |
| Other Expenses | - | 14.84 Million | -2.5 Million | -773.92 Million | -411.52 Million | 8.15 Million |
| Cost and Expenses | 2.39 Billion | 2.4 Billion | 2.75 Billion | 6.01 Billion | 22.08 Billion | 5.54 Billion |
| Operating Income | -130.93 Million | -256.56 Million | -349.97 Million | -1.74 Billion | -2.66 Billion | -569.73 Million |
| Interest Expense | 116.26 Million | 109.5 Million | 109.74 Million | 194.19 Million | 549.98 Million | 120.96 Million |
| Income Tax Expense | 40.95 Million | -2.21 Million | -5.15 Million | 99.54 Million | 87.05 Million | -5.43 Million |
| Earnings before Tax | -259.28 Million | -277.22 Million | -376.77 Million | -2.12 Billion | -3.66 Billion | -559.82 Million |
| Net Income | -278.98 Million | -247.98 Million | -292.01 Million | -2.36 Billion | -3.65 Billion | -480.56 Million |
| Earnings Per Share Basic | -0.32 | -0.28 | -0.34 | -2.72 | - | -0.55 |
| Earnings Per Share Diluted | -0.32 | -0.28 | -0.34 | -2.72 | - | -0.55 |
| Weighted Average Shares Outstanding | 870.27 Million | 870.27 Million | 858.88 Million | 867.99 Million | 867.17 Million | 870.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 870.27 Million | 870.27 Million | 858.88 Million | 867.99 Million | 867.17 Million | 870.63 Million |
| Gross Margin | 0.08 | 0.06 | -0.02 | -0.15 | -0.06 | -0.03 |
| EBIT Margin | -0.06 | -0.08 | -0.14 | -0.34 | - | -0.08 |
| Profit Margin | -0.12 | -0.11 | -0.12 | -0.55 | -0.19 | -0.09 |
| EBITDA | -143.02 Million | -169.68 Million | -326.81 Million | -1.43 Billion | - | -421.9 Million |
| Earnings Before Tax Margin | -0.06 | -0.11 | -0.15 | -0.41 | -0.14 | -0.11 |
1572
DORM
PENTA
HOCL
ABTZY
0973